Analysis of the Indian Pharmaceutical Industry With Emphasis on Opportunities in 2005

mation superhighway have brought the countries of the world closer. From a business perspective, the world is one marketplace. The American pharmaceutical industry has played a pioneering role in the development of the drug industry through in-depth, timely, and useful research and bulk manufacturing of drug products. Although the US pharmaceutical industry is enjoying the leadership position, it can no longer be content to focus only on the US, Japanese, and European markets. Two recent articles that analyzed the Chinese and Hungarian pharmaceutical markets showed that during the 1990s, the Chinese pharmaceutical market experienced overestimated demand and severe undercapacity use, and the Hungarian pharmaceutical market suffered setbacks in the same decade and was forced to adopt new strategies to revive the industry (1,2). India, being the second largest country in the world in terms of population, is also attracting attention for future business potential. The purchasing capacity of approximately 300 million middle-class individuals cannot be easily overlooked by global